218 related articles for article (PubMed ID: 26645980)
21. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
22. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
[TBL] [Abstract][Full Text] [Related]
23. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
[TBL] [Abstract][Full Text] [Related]
24. Development and therapeutic impact of HDAC6-selective inhibitors.
Dallavalle S; Pisano C; Zunino F
Biochem Pharmacol; 2012 Sep; 84(6):756-65. PubMed ID: 22728920
[TBL] [Abstract][Full Text] [Related]
25. Chromatin modifications remodel cardiac gene expression.
Mathiyalagan P; Keating ST; Du XJ; El-Osta A
Cardiovasc Res; 2014 Jul; 103(1):7-16. PubMed ID: 24812277
[TBL] [Abstract][Full Text] [Related]
26. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.
Zhou B; Margariti A; Zeng L; Xu Q
Cardiovasc Res; 2011 Jun; 90(3):413-20. PubMed ID: 21233251
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylases in cardiac fibrosis: current perspectives for therapy.
Tao H; Shi KH; Yang JJ; Huang C; Zhan HY; Li J
Cell Signal; 2014 Mar; 26(3):521-7. PubMed ID: 24321371
[TBL] [Abstract][Full Text] [Related]
29. Non-sirtuin histone deacetylases in the control of cardiac aging.
Ferguson BS; McKinsey TA
J Mol Cell Cardiol; 2015 Jun; 83():14-20. PubMed ID: 25791169
[TBL] [Abstract][Full Text] [Related]
30. The biology and therapeutic implications of HDACs in the heart.
McKinsey TA
Handb Exp Pharmacol; 2011; 206():57-78. PubMed ID: 21879446
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein-inducing compounds as therapeutics to restore proteostasis in atrial fibrillation.
Hoogstra-Berends F; Meijering RA; Zhang D; Heeres A; Loen L; Seerden JP; Kuipers I; Kampinga HH; Henning RH; Brundel BJ
Trends Cardiovasc Med; 2012 Apr; 22(3):62-8. PubMed ID: 22863365
[TBL] [Abstract][Full Text] [Related]
32. Post-translational modifications talk and crosstalk to class IIa histone deacetylases.
Guttzeit S; Backs J
J Mol Cell Cardiol; 2022 Jan; 162():53-61. PubMed ID: 34416247
[TBL] [Abstract][Full Text] [Related]
33. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells.
Ganai SA; Kalladi SM; Mahadevan V
J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937
[TBL] [Abstract][Full Text] [Related]
34. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
35. Interplay between histone deacetylases and autophagy--from cancer therapy to neurodegeneration.
Trüe O; Matthias P
Immunol Cell Biol; 2012 Jan; 90(1):78-84. PubMed ID: 22124372
[TBL] [Abstract][Full Text] [Related]
36. Prevention of Atrial Fibrillation: Putting Proteostasis Derailment Back on Track.
Kishore P; Collinet ACT; Brundel BJJM
J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445387
[TBL] [Abstract][Full Text] [Related]
37. Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.
Weeks KL; Avkiran M
J Physiol; 2015 Apr; 593(8):1785-97. PubMed ID: 25362149
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
Wang Z; Zhao YT; Zhao TC
Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
40. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
Simões-Pires C; Zwick V; Nurisso A; Schenker E; Carrupt PA; Cuendet M
Mol Neurodegener; 2013 Jan; 8():7. PubMed ID: 23356410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
